Phase I clinical trials remain essential for new drug development, identifying new treatment pathways, and identifying ...
Cornell University is enrolling client-owned cats in an 11-week trial of AKS-562c, a once-weekly GLP-1 Fc-fusion candidate designed to reduce appetite and produce clinically meaningful weight loss ...
Following its FDA 510 (k) clearance last year, SOMNUM™ has been formally recognized as a validated analytical tool for ...
cSchool of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru dInstituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru eSchool of Medicine, ...
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...
"I just know that my brain's not right," said Carrie Richardson, 44. "And so, I hate it. I just want it to be normal." At 41, Carrie developed early-onset Alzheimer's disease. The condition is caused ...
75% Objective Response Rate as 12 out of 16 advanced melanoma patients had objective clinical responses, with 11 of the 12 responders continuing to respond at 24 months follow-up Immune activation ...
Background: Post-exercise stretching is widely employed in athletic and rehabilitation settings to promote recovery and performance. However, its physiological benefits remain controversial due to ...
QBiotics CEO, Stephen Doyle, reflecting on Soft Tissue Sarcoma data Positive data from Stage 1 of the Phase IIa clinical trial (QB46C-H07) evaluating QBiotics' small molecule, tigilanol tiglate in 11 ...
Positive data from Stage 1 of the Phase IIa clinical trial (QB46C-H07) evaluating QBiotics' small molecule, tigilanol tiglate in 11 (10 evaluable) patients with advanced Soft Tissue Sarcoma (STS). An ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results